Biologics Spine Cerapedics’ i-FACTOR P-15 Peptide Enhanced Bone Graft, a Trusted Choice in Bone Graft Solutions, Now Approved for Expanded Indications for Use byJosh SandbergSeptember 24, 2024
Biologics Spine Top Stories Cerapedics Announces Publication of Results of Study Evaluating the Cost-Effectiveness of i-FACTOR vs. Local Autologous Bone in ACDF Surgery byJosh SandbergAugust 17, 2021
Biologics Regulatory Spine Cerapedics Announces FDA Approval of PMA Supplement Based on Two-Year Clinical Data byJosh SandbergNovember 18, 2019
Biologics Top Stories Cerapedics Announces i-FACTOR™ Peptide Enhanced Bone Graft Adopted by More than 150 Leading U.S. Hospitals byJosh SandbergOctober 26, 2017
Hospitals Cerapedics Receives FDA Approval for i-FACTOR™ Peptide Enhanced Bone Graft in Cervical Spine Surgery byJosh SandbergNovember 5, 2015
